Abstract:Myotonic dystrophy type 2 (DM2) is an autosomal-dominant multisystemic disease with a core manifestation of proximal muscle weakness, muscle atrophy, myotonia, and myalgia. The disease-causing CCTG tetranucleotide expansion within the CNBP gene on chromosome 3 leads to an RNA-dominated spliceopathy, which is currently untreatable. Research exploring the pathophysiological mechanisms in myotonic dystrophy type 1 has resulted in new insights into disease mechanisms and identified mitochondrial dysfunction as a promising therapeutic target. It remains unclear whether similar mechanisms underlie DM2 and, if so, whether these might also serve as potential therapeutic targets. In this cross-sectional study, we studied DM2 skeletal muscle biopsy specimens on proteomic, molecular, and morphological, including ultrastructural levels in two separate patient cohorts consisting of 8 (explorative cohort) and 40 (confirmatory cohort) patients. Seven muscle biopsy specimens from four female and three male DM2 patients underwent proteomic analysis and respiratory chain enzymology. We performed bulk RNA sequencing, immunoblotting of respiratory chain complexes, mitochondrial DNA copy number determination, and long-range PCR (LR-PCR) to study mitochondrial DNA deletions on six biopsies. Proteomic and transcriptomic analyses revealed a downregulation of essential mitochondrial proteins and their respective RNA transcripts, namely of subunits of respiratory chain complexes I, III, and IV (e.g., mt-CO1, mt-ND1, mt-CYB, NDUFB6) and associated translation factors (TACO1). Light microscopy showed mitochondrial abnormalities (e.g., an age-inappropriate amount of COX-deficient fibers, subsarcolemmal accumulation) in most biopsy specimens. Electron microscopy revealed widespread ultrastructural mitochondrial abnormalities, including dysmorphic mitochondria with paracrystalline inclusions. Immunofluorescence studies with co-localization of autophagy (p62, LC-3) and mitochondrial marker proteins (TOM20, COX-IV), as well as immunohistochemistry for mitophagy marker BNIP3 indicated impaired mitophagic flux. Immunoblotting and LR-PCR did not reveal significant differences between patients and controls. In contrast, mtDNA copy number measurement showed a reduction of mtDNA copy numbers in the patient group compared to controls. This first multi-level study of DM2 unravels thus far undescribed functional and structural mitochondrial abnormalities. However, the molecular link between the tetranucleotide expansion and mitochondrial dysfunction needs to be further elucidated.

Correlation between CTG trinucleotide repeat length and frequency of severe congenital myotonic dystrophy

Molecular genetics of congenital myotonic dystrophy

Clinical analysis and gene mutation screening of CLCN1 in two myotonia congenita families

Correlation Between CTG Trinucleotide Repetition Numbers of Gene in Myotonic Dystrophy and Electrocardiographic Findings

CTG repeat length underlying cardiac events and sudden death in myotonic dystrophy type 1

(Tttca)exp Drives the Genotype-Phenotype Correlation and Genetic Anticipation in FCMTE1.

DNA Analysis of a Pedigree with Myotonic Dystrophy in Songjiang County, Shanghai.

Comparion of CTG trinucleotide repeat numbers in blood and muscle tissues of myotoonic dystrophy

CCG interruptions are unstable and hypermethylated in DM1 patients

The Novel Mitochondrial 16S Rrna 2336T>C Mutation is Associated with Hypertrophic Cardiomyopathy

Congenital and childhood myotonic dystrophy: Current aspects of disease and future directions

Aberrant Myokine Signaling in Congenital Myotonic Dystrophy

[Application of triplet-primer PCR technology for the genetic testing and prenatal diagnosis of patients with Myotonic dystrophy type 1]

Cataract and Myotonic Dystrophy: the Role of Molecular Diagnosis

Towards development of a statistical framework to evaluate myotonic dystrophy type 1 mRNA biomarkers in the context of a clinical trial

Dosage effect of multiple genes accounts for multisystem disorder of myotonic dystrophy type 1.

Abstract 050: Mutational Spectrum in a Cohort of Chinese Sporadic Dilated Cardiomyopathy by Next-generation Sequencing

Congenital Myotonic Dystrophy: Canadian Population-Based Surveillance Study

Multi-level profiling unravels mitochondrial dysfunction in myotonic dystrophy type 2

Effects of interrupting residues on DNA dumbbell structures formed by CCTG tetranucleotide repeats associated with myotonic dystrophy type 2

Developing a one-step triplet-repeat primed PCR assay for diagnosing myotonic dystrophy